SCHEMBL23809161

SCHEMBL23809161

CC(C)c1c(C(=O)O)ccc2ccccc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
WDR5 P61964 1/20 0.59
LDHA P00338 1/20 0.58
NR4A1 P22736 1/20 0.53
NR4A2 P43354 1/20 0.53
NR4A3 Q92570 1/20 0.53
NCEH1 Q6PIU2 1/20 0.51
CDC25B P30305 1/20 0.47
ALDH1A1 P00352 4/20 0.45
KDM4E B2RXH2 4/20 0.45
HPGD P15428 3/20 0.45
LMNA P02545 1/20 0.44
CSNK2A2 P19784 1/20 0.44
CSNK2B P67870 1/20 0.44
CSNK2A1 P68400 1/20 0.44
PSEN1 P49768 1/20 0.43
PSEN2 P49810 1/20 0.43
APH1B Q8WW43 1/20 0.43
NCSTN Q92542 1/20 0.43
APH1A Q96BI3 1/20 0.43
PSENEN Q9NZ42 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9807649 0.86 NCEH1 (0.51) WDR5LDHANR4A1NR4A2NR4A3
SCHEMBL19695770 0.84 NCEH1 (0.50) WDR5LDHANR4A1NR4A2NR4A3
SCHEMBL7477120 0.84 NCEH1 (0.54) WDR5LDHANCEH1ALDH1A1KDM4E
SCHEMBL14150964 0.83 WDR5 (0.53) WDR5LDHANR4A1NR4A2NR4A3
SCHEMBL11308992 0.82 WDR5 (0.51) WDR5LDHANR4A1NR4A2NR4A3
SCHEMBL12355057 0.80 NCEH1 (0.47) WDR5LDHANCEH1ALDH1A1KDM4E
SCHEMBL7539671 0.80 WDR5 (0.49) WDR5LDHANR4A1NR4A2NR4A3
SCHEMBL8609970 0.79 NCEH1 (0.44) WDR5LDHANCEH1ALDH1A1KDM4E
SCHEMBL28789417 0.78 WDR5 (0.54) WDR5LDHANR4A1NR4A2NR4A3
SCHEMBL21686452 0.78 POLB (0.58) LDHANR4A1NR4A2NR4A3CDC25B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2021-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS MCL1, BCL2L1, BCL9 WDR5 1650/4885LDHA 3048/4885NR4A1 3610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.